These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11450668)

  • 1. Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
    Redmond DE; Sladek JR; Spencer DD
    N Engl J Med; 2001 Jul; 345(2):146-7. PubMed ID: 11450668
    [No Abstract]   [Full Text] [Related]  

  • 2. Neural transplants in Parkinson's disease. CPH Neural Transplantation Group.
    Lopez-Lozano JJ; Brera B
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1005-11. PubMed ID: 8442023
    [No Abstract]   [Full Text] [Related]  

  • 3. Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
    Olanow CW; Freeman T; Kordower J
    N Engl J Med; 2001 Jul; 345(2):146; author reply 147. PubMed ID: 11450669
    [No Abstract]   [Full Text] [Related]  

  • 4. Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
    Freed CR; Greene PE; Breeze RE; Tsai WY; DuMouchel W; Kao R; Dillon S; Winfield H; Culver S; Trojanowski JQ; Eidelberg D; Fahn S
    N Engl J Med; 2001 Mar; 344(10):710-9. PubMed ID: 11236774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient.
    Piccini P; Brooks DJ; Björklund A; Gunn RN; Grasby PM; Rimoldi O; Brundin P; Hagell P; Rehncrona S; Widner H; Lindvall O
    Nat Neurosci; 1999 Dec; 2(12):1137-40. PubMed ID: 10570493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embryonic dopamine cell implants as a treatment for the second phase of Parkinson's disease. Replacing failed nerve terminals.
    Freed CR; Breeze RE; Rosenberg NL; Schneck SA
    Adv Neurol; 1993; 60():721-8. PubMed ID: 8420217
    [No Abstract]   [Full Text] [Related]  

  • 7. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease.
    Spencer DD; Robbins RJ; Naftolin F; Marek KL; Vollmer T; Leranth C; Roth RH; Price LH; Gjedde A; Bunney BS
    N Engl J Med; 1992 Nov; 327(22):1541-8. PubMed ID: 1435880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplanted allogeneic fetal dopamine neurons survive and improve motor function in idiopathic Parkinson's disease.
    Widner H; Brundin P; Rehncrona S; Gustavii B; Frackowiak R; Leenders KL; Sawle G; Rothwell JC; Marsden CD; Björklund A
    Transplant Proc; 1991 Feb; 23(1 Pt 1):793-5. PubMed ID: 1990693
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell therapy for Parkinson's disease.
    Fischbach GD; McKhann GM
    N Engl J Med; 2001 Mar; 344(10):763-5. PubMed ID: 11236783
    [No Abstract]   [Full Text] [Related]  

  • 10. Fetal-tissue transplants in Parkinson's disease.
    Fahn S
    N Engl J Med; 1992 Nov; 327(22):1589-90. PubMed ID: 1435887
    [No Abstract]   [Full Text] [Related]  

  • 11. Do patients with Parkinson's disease benefit from embryonic dopamine cell transplantation?
    Freed CR; Leehey MA; Zawada M; Bjugstad K; Thompson L; Breeze RE
    J Neurol; 2003 Oct; 250 Suppl 3():III44-6. PubMed ID: 14579124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unilateral fetal mesencephalic grafting in two patients with Parkinson's disease: short-term result after transplantation.
    Chung CK; Kim HJ; Jeon BS; Kim YS; Lee SB; Han DH
    No Shinkei Geka; 1996 Nov; 24(11):987-93. PubMed ID: 8934466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved surgical cell therapy in Parkinson's disease. Physiological basis and new transplantation methodology.
    Isacson O; van Horne C; Schumacher JM; Brownell AL
    Adv Neurol; 2001; 86():447-54. PubMed ID: 11554007
    [No Abstract]   [Full Text] [Related]  

  • 14. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease.
    Freed CR; Breeze RE; Rosenberg NL; Schneck SA; Kriek E; Qi JX; Lone T; Zhang YB; Snyder JA; Wells TH
    N Engl J Med; 1992 Nov; 327(22):1549-55. PubMed ID: 1435881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional integration of neural grafts in Parkinson's disease.
    Barker RA; Dunnett SB
    Nat Neurosci; 1999 Dec; 2(12):1047-8. PubMed ID: 10570477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural stem cells and Parkinson's disease.
    Storch A; Schwarz J
    J Neurol; 2002 Oct; 249 Suppl 3():III/30-2. PubMed ID: 12522569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease. Signs of disease in fetal transplants.
    Miller G
    Science; 2008 Apr; 320(5873):167. PubMed ID: 18403684
    [No Abstract]   [Full Text] [Related]  

  • 18. Neural transplantation in Parkinson's disease: the Swedish experience.
    Lindvall O; Rehncrona S; Brundin P; Gustavii B; Astedt B; Widner H; Lindholm T; Björklund A; Leenders KL; Rothwell JC
    Prog Brain Res; 1990; 82():729-34. PubMed ID: 2290977
    [No Abstract]   [Full Text] [Related]  

  • 19. Parkinson's disease: interpretations of transplantation study are erroneous.
    Isacson O; Bjorklund L; Pernaute RS
    Nat Neurosci; 2001 Jun; 4(6):553. PubMed ID: 11369929
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intracerebral grafts in Parkinson disease. Current experiences and perspectives].
    Levivier M
    Bull Mem Acad R Med Belg; 1999; 154(1):99-106; discussion 106-9. PubMed ID: 10535160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.